Maternity and Child Care (MCC) Hospitals Market in India - A $27.63 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Maternity and Child Care (MCC) Hospitals market in India is expected to be worth US$ 27.63 billion by 2020, finds a new research report launched by NOVONOUS. Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 38% by 2020. This growth is driven by India’s rapidly increasing aspirational middle class population, increase in per capita income of urban India with considerable amount disposable income, increasing participation of women in the workforce which in turn has given rise to the count of dual income household and availability of multiple financing options for the customers which predominantly includes customized insurance plans & loan repayment EMI's.

To know more about this newly launched market research report visit “Maternity and Child Care (MCC) Hospitals Market in India 2015-2020”

Birthing services currently control the largest market share in terms of revenue in Indian maternity and child care (MCC) hospitals market. As per NOVONOUS estimates, birthing services segment in Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 38.73% till 2020 and maintain its market share position even in 2020.

Pre-natal services currently control the second largest market share in terms of revenue in Indian maternity and child care (MCC) hospitals market. As per NOVONOUS estimates, pre-natal services segment in Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 41.98% till 2020 and maintain its market share position.

Post-natal services segment in Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 18.81% till 2020.

Fertility services segment in Indian maternity and child care (MCC) hospitals market is expected to grow at a CAGR of 12.25% till 2020.

Spanning over 136 pages and 109 exhibits, “Maternity and Child Care (MCC) Hospitals Market in India 2015-2020” report presents an in-depth assessment of the maternity and child care (MCC) hospitals market from 2015 till 2020.

The report has detailed company profiles including their position in maternity and child care (MCC) hospitals market value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for ten key players in Indian market namely Apollo Bangalore Cradle Limited (ABCL), Kids Clinic India Pvt. Ltd. (Cloudnine Hospitals), Fortis La Femme Limited, Gunasheela Surgical & Maternity Hospital, Kilkari Mother and Child Hospital, LifeSpring Hospitals Pvt. Ltd. (LHPL), Motherhood Hospitals, Rainbow Children’s Hospital Pvt. Ltd., Fortis The Nest and Birthplace Healthcare Pvt. Ltd.

Scope of Maternity and Child Care (MCC) Hospitals Market in India 2015 - 2020 report:

• This report provides a detailed view of Indian maternity and child care (MCC) hospitals market.
• This report identifies the need for focusing on maternity and child care (MCC) hospitals sector in India.
• This report provides detailed information on market scenario for overall maternity and child care (MCC) hospitals  industry in India up from 2010-2014 (in US$ billion).
• This report provides detailed information on service wise (pre-natal, birthing, post-natal and fertility) market scenario for maternity and child care (MCC) hospitals market in India from 2010-2014 (in US$ billion).
• This report provides detailed information on growth forecasts for overall maternity and child care (MCC) hospitals industry in India from 2015-2020 (in US$ billion).
• This report provides detailed information on service wise (pre-natal, birthing, post-natal and fertility) growth forecasts for maternity and child care (MCC) hospitals market in India from 2015-2020 (in US$ billion).
• This report identifies the growth drivers and inhibitors for maternity and child care (MCC) hospitals market in India.
• This study also identifies policies related to maternity and child care (MCC) hospitals market in India.
• The report identifies various credit, policy and technical risks associated with maternity and child care (MCC) hospitals market in India.
• This report has detailed profiles 10 key players in Indian maternity and child care (MCC) hospitals market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
• This report covers in details the competitive landscape in Indian maternity and child care (MCC) hospitals market.
• This report identifies key industry bodies and associations and their role in Indian maternity and child care (MCC) hospitals market.
• This report identifies key government bodies and their role in Indian maternity and child care (MCC) hospitals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian maternity and child care (MCC) hospitals market.
• This report provides Porter's Five Forces analysis for maternity and child care (MCC) hospitals market in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for maternity and child care (MCC) hospitals market in India.
• This report provides challenges faced by new players in maternity and child care (MCC) hospitals market in India.
• This report provides future trends and opportunities for maternity and child care (MCC) hospitals market in India.
• This report also provides strategic recommendations for end user, policy makers and maternity and child care (MCC) hospitals.
• This report also has a detailed case study on "Apollo Cradle – Engaging Families & Delivering Joy" topic.

For more information and purchase this report please visit:

http://www.marketresearchreports.com/novonous/maternity-and-child-care-mcc-hospitals-market-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Pharmaceuticals Retailing Industry in India - A $32.80 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Pharmaceuticals Retailing Industry in India is expected to be worth US$ 32.80 billion by 2020, finds a new research report launched by NOVONOUS. Indian pharmaceuticals retailing market is expected to grow at a CAGR of 5% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.

To know more about this newly launched market research report visit “Pharmaceuticals Retailing Industry in India 2015-2020”

The pharmaceuticals retailing market in India is largely unorganized and fragmented. The market is wide spread within the urban landscape while the rural area is largely underserved. This is compounded by the fact the Indian pharmaceuticals retail industry uses elongated logistics and distribution chains resulting in poor management and sometime counterfeiting.

Spanning over 72 pages and 45 exhibits, “Pharmaceuticals Retailing Industry in India 2015-2020” report presents an in-depth assessment of the pharmaceuticals retailing industry from 2015 till 2020.

The report also has detailed company profiles including their position in pharmaceuticals retailing industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for two key players in Indian market namely Apollo Pharmacy and MedPlus Health Services Pvt. Ltd.

Scope of Pharmaceuticals Retailing Industry in India 2015 - 2020 report:

• This report provides a detailed view of Indian pharmaceuticals retailing market.
• This report identifies the need for focusing on pharmaceuticals sector in India.
• This report provides detailed information on growth forecasts for pharmaceuticals retailing industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for pharmaceuticals retailing industry in India.
• This study also identifies policies related to pharmaceuticals market in India.
• The report identifies various credit, policy and technical risks associated with pharmaceuticals retailing industry in India.
• The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India.
• The report identifies top countries exporting pharmaceuticals products and medical devices to India.
• The report identifies top countries importing pharmaceuticals products and medical devices from India.
• This report has detailed profiles 2 key players in Indian pharmaceuticals retailing market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
• This report identifies key industry bodies and associations and their role in Indian pharmaceuticals retailing market.
• This report identifies key government bodies and their role in Indian pharmaceuticals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals retailing market.
• This report provides Porter's Five Forces analysis for pharmaceuticals retailing industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals retailing industry in India.
• This report provides future trends and opportunities for pharmaceuticals retailing market in India.
• This report also provides strategic recommendations for policy makers and pharmaceuticals retailers.

For more information and purchase this report please visit: http://www.marketresearchreports.com/novonous/pharmaceuticals-retailing-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Pharmaceuticals Packaging Industry in India - A $2.60 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Pharmaceuticals packaging Industry in India is expected to be worth US$ 2.60 billion by 2020, finds a new research report launched by NOVONOUS. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases. This is directly going to affect pharmaceuticals packaging industry in India which is expected to grow at a CAGR of 5.46% till 2020.

To know more about this newly launched market research report visit “Pharmaceuticals Packaging Industry in India 2015-2020”

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers. The growth of Indian pharmaceuticals packaging industry is directly linked to growth of pharmaceutical manufacturing industry.

India’s Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

Spanning over 59 pages and 37 exhibits, “Pharmaceuticals Packaging Industry in India 2015-2020” report presents an in-depth assessment of the pharmaceuticals packaging industry from 2015 till 2020.

 

Scope of the Pharmaceuticals Packaging Industry in India 2015 - 2020 Report

• This report provides a detailed view of Indian pharmaceuticals packaging market.
• This report identifies the need for focusing on pharmaceuticals sector in India.
• This report provides detailed information on growth forecasts for global pharmaceuticals packaging industry up to 2020.
• This report provides detailed information on growth forecasts for pharmaceuticals packaging industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for pharmaceuticals packaging industry in India.
• This study also identifies policies related to pharmaceuticals market in India.
• The report identifies various credit, policy and technical risks associated with pharmaceuticals packaging industry in India.
• This study also identifies policies related to pharmaceuticals packaging market in India for various sectors.
• The report identifies various credit, policy and technical risks associated with pharmaceuticals packaging industry in India.
• The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India.
• The report identifies top countries exporting pharmaceuticals products and medical devices to India.
• The report identifies top countries importing pharmaceuticals products and medical devices from India.
• This report identifies key industry bodies and associations and their role in Indian pharmaceuticals packaging market.
• This report identifies key government bodies and their role in Indian pharmaceuticals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals packaging market.
• This report provides Porter's Five Forces analysis for pharmaceuticals packaging industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals packaging industry in India.
• This report provides future trends and opportunities for pharmaceuticals packaging market in India.
• This report also provides strategic recommendations for policy makers and pharmaceuticals packaging manufacturers.

For more information and purchase this report please visit:

http://www.marketresearchreports.com/novonous/pharmaceuticals-packaging-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Huge Opportunities in Indian Medical Services Industry By 2020, Reveals New Market Research Report by NOVONOUS

Medical Services Industry which predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others is expected to create huge opportunities in Indian market by 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% and reach US$ 1.004 billion by 2020, finds a new research report launched by NOVONOUS.

In the sphere of Telemedicine in India, Private players contribute to the chunk of the market size. Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% and reach US$ 24.37 million by 2020.

To know more about this newly launched market research report visit “Medical Services Industry in India 2015-2020”

Spanning over 51 pages and 30 exhibits, “Medical Services Industry in India 2015-2020” report presents an in-depth assessment of the medical services industry from 2015 till 2020.

 

Scope of Medical Services Industry in India 2015 - 2020 report:

• This report provides a detailed view of Indian medical services market.
• This report identifies the need for focusing on medical services sector in India.
• This report provides detailed information on growth forecasts for medical transcription industry in India up to 2020.
• This report provides detailed information on growth forecasts for private sector telemedicine industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for medical services industry in India.
• This study also identifies policies related to pharmaceuticals market in India.
• The report identifies various credit, policy and technical risks associated with medical services industry in India.
• This report identifies key industry bodies and associations and their role in Indian medical services market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian medical services market.
• This report provides Porter's Five Forces analysis for medical services industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for medical services industry in India.
• This report also provides strategic recommendations for policy makers and medical services providers.

For more information and purchase this report please visit:

http://www.marketresearchreports.com/novonous/medical-services-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Medical Devices Manufacturing Industry in India - A $5.78 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Medical Devices Manufacturing Industry in India is expected to be worth US$ 5.78 billion by 2020, finds a new research report launched by NOVONOUS. Indian medical device manufacturing market is expected to grow at a CAGR of 15% by 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.

To know more about this newly launched market research report visit Medical Devices Manufacturing Industry in India 2015-2020

Spanning over 90 pages and 88 exhibits, “Medical Devices Manufacturing Industry in India 2015-2020” report presents an in-depth assessment of the medical device manufacturing industry from 2015 till 2020.

The report has detailed company profiles including their position in medical device manufacturing industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for three key players in Indian market namely Beacton  Dickinson & Company Limited, Poly Medicure Limited and Novartis India Limited.

 

Scope of Medical Devices Manufacturing Industry in India 2015 - 2020 report:

• This report provides a detailed view of Indian medical devices manufacturing market.
• This report identifies the need for focusing on pharmaceuticals sector in India.
• This report provides detailed information on growth forecasts for medical devices manufacturing industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for medical devices manufacturing industry in India.
• This study also identifies policies related to pharmaceuticals market in India.
• The report identifies various credit, policy and technical risks associated with medical devices manufacturing industry in India.
• The report identifies EXIM scenario for medical devices market in India.
• The report identifies top countries exporting medical devices to India.
• The report identifies top countries importing medical devices from India.
• This report has detailed profiles 3 key players in Indian medical devices manufacturing market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
• This report covers in details the competitive landscape in Indian medical devices manufacturing market.
• This report identifies key industry bodies and associations and their role in Indian medical devices manufacturing market.
• This report identifies key government bodies and their role in Indian pharmaceuticals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian medical devices manufacturing market.
• This report provides Porter's Five Forces analysis for medical devices manufacturing industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for medical devices manufacturing industry in India.
• This report also provides strategic recommendations for policy makers and medical device manufacturers.

For more information and purchase this report please visit:

http://www.marketresearchreports.com/novonous/medical-devices-manufacturing-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Pharmaceuticals Manufacturing Industry in India - A $41.92 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Pharmaceuticals Manufacturing Industry in India is expected to be worth US$ 41.92 billion by 2020, finds a new research report launched by NOVONOUS. Indian pharmaceuticals manufacturing market is expected to grow at a CAGR of 19.76% by 2020. This is despite slowing growth in developed markets; players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.

To know more about this newly launched market research report visit “Pharmaceuticals Manufacturing Industry in India 2015-2020”

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India’s Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

Spanning over 176 pages and 174 exhibits, “Pharmaceuticals Manufacturing Industry in India 2015-2020” report presents an in-depth assessment of the pharmaceuticals manufacturing industry from 2015 till 2020.

The report has detailed company profiles including their position in pharmaceuticals manufacturing industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for ten key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy’s Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited and IPCA Laboratories Limited.

 

Scope of Pharmaceuticals Manufacturing Industry in India 2015 - 2020 report:

• This report provides a detailed view of Indian pharmaceuticals manufacturing market.
• This report identifies the need for focusing on pharmaceuticals sector in India.
• This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing industry in India.
• This study also identifies policies related to pharmaceuticals market in India.
• The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing industry in India.
• The report identifies EXIM scenario for pharmaceuticals products market in India.
• The report identifies top countries exporting pharmaceuticals products to India.
• The report identifies top countries importing pharmaceuticals products from India.
• This report has detailed profiles 10 key players in Indian pharmaceuticals manufacturing market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
• This report covers in details the competitive landscape in Indian pharmaceuticals manufacturing market.
• This report identifies key industry bodies and associations and their role in Indian pharmaceuticals manufacturing market.
• This report identifies key government bodies and their role in Indian pharmaceuticals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals manufacturing market.
• This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing industry in India.
• This report provides future trends and opportunities for pharmaceuticals manufacturing market in India.
• This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.

For more information and purchase this report please visit:

http://www.marketresearchreports.com/novonous/pharmaceuticals-manufacturing-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 - a G-CSF & GM-CSF Competitor Analysis, New Report Launched

The Competitive Intelligence report Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis describes product portfolios and R&D pipelines of granulocyte colony stimulating factor (G-CSF) and GM-CSF products and product candidates in regulated and in less regulated markets as of July 2015. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and allow online work with the project data to print or export an individual report.

With 2014 sales of about US$ 6 bln, first and next generation G-CSF products represent an attractive market size for biosimilar proteins in regulated markets. Biosimilar filgrastim products have already been introduced into the the European Union and now are also entering the US market. Importantly, biosimilar products from Indian companies are among the approved products indicating that Indian companies can fulfill Western standards of cGMP manufacturing and cGCP development of at least relatively simple therapeutic proteins such as filgrastim.

The report includes a compilation of currently marketed branded and non-branded G-CSF and GM-CSF products in regulated and less regulated markets for treatment of chemotherapy-induced neutropenia. The report includes the market size of branded G-CSF products in 2014. In addition, the report lists company-specific product portfolios and R&D pipelines of G-CSF/GM-CSF products and projects. Competitor projects are listed in a tabular format providing information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product Category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.

About Competitor Analysis Series:

The Competitor Analysis Series delivers NO-FRILLS, but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies at low prices. The information is provided in a tabular format and fully referenced.

2014 Sales of Branded Filgrastim, Lenograstim & Pegfilgrastim Products

Filgrastim & Lenograstim: Originator, Biosimilar & Biosuperior Products in EU

Filgrastim: Originator, Biosimilar & Biosuperior Products in USA

Filgrastim, Lenograstim & Nartograstim: Originator, Biosimilar & Biosuperior Products in Japan

Filgrastim: Biosimilar Products in India, Pakistan & Bangladesh

Filgrastim: Biosimilar Products in China & Taiwan

Filgrastim: Biosimilar Products in South Korea

Filgrastim & Lenograstim: Biosimilar Products in Latin America

Filgrastim: Biosimilar Products in Other Less Regulated Markets

Pegfilgrastim: Originator, Biosimilar & Biosuperior Products in EU

Pegfilgrastim: Originator, Biosimilar & Biosuperior Products in USA

Pegfilgrastim: Originator, Biosimilar & Biosuperior Products in Japan

Pegfilgrastim: Biosimilar Products in India & Pakistan

Pegfilgrastim: Biosimilar & Biosuperior Products in China & Taiwan

Pegfilgrastim: Biosimilar & Biosuperior Products in South Korea

Pegfilgrastim: Biosimilar Products in Other Less Regulated Markets

GM-CSF: Sargramostim Originator & Biosimilar Products worldwide

GM-CSF: Molgramostim Originator & Biosimilar Products worldwide

Corporate Filgrastim & Pegfilgrastim Biosimilar & Biosuperior Portfolios

For further information on this report, please visit- http://mrr.cm/oky

Related Reports:

1st- Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists - visit at: http://mrr.cm/okF

2nd- 2014 Sales of Recombinant Therapeutic Antibodies & Proteins - visit at: http://mrr.cm/okt

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions

Pharmaceuticals Industry in India - A $55.39 billion Opportunity By 2020, Reveals New Market Research Report by NOVONOUS

Pharmaceuticals Industry in India is expected to be worth US$ 55.39 billion by 2020, finds a new research report launched by NOVONOUS. Indian pharmaceuticals market is expected to grow at a CAGR of 18% by 2020 driven by the aging and growing population, rising income levels, emerging medical conditions and new diseases.

To know more about this newly launched market research report visit “Pharmaceuticals Industry in India 2015-2020”

The Indian Pharmaceutical Industry is in middle of big changes and not only the Industry is expected to accommodate Demographic, Epidemiological, and economic shifts in the world, but also has to upgrade manufacturing practices and match rigid standards from time to time in order to produce world-class medicines. Also, the pharmaceutical manufacturers are expected to embrace newer methods and effective practices - right from the ways drugs are discovered, then on manufacturing and packaging fronts, and to the ways drugs are made available to consumers.

The generics portfolio dominates the Indian Pharma Industry which accounts for over 70% of the market. The Indian Pharma market is largely fragmented. With a string of Mergers and Acquisitions within the market in the last decade, consolidation of the overall market has been the key Industry feature.

India’s Pharmaceutical sector accounts for nearly 1.4% of the global pharmaceutical industry in terms of value 10% in terms of volume.

As per NOVONOUS estimates, pharmaceuticals manufacturing industry in India is expected to grow at a CAGR of 19.76% till 2020. Despite slowing growth in developed markets, players in generics are expected to perform reasonably well due to significant numbers of exclusivity losses and patent expirations on leading drugs in the upcoming years.

Medical devices manufacturing industry in India is expected to grow at a CAGR of 15% till 2020. Indian Medical Devices and Equipment industry is an import-led market and about 70%-80% of finished goods and related components are sourced from foreign countries. This trend is expected to continue till 2020.

Indian medical transcription Industry is expected to grow at a CAGR of 4.16% till 2020 found this study. The Pharma service predominantly includes Medical Transcription, Telemedicine, Clinical Trials, Clinical Data Management and Teleradiology amongst the others.

Private sector telemedicine industry in India is expected to grow at a CAGR of 12.35% till 2020.

On the other hand, Pharmaceuticals packaging industry in India is expected to grow at a CAGR of 5.46% till 2020.

NOVONOUS estimates that pharmaceuticals retail industry in India will grow at a CAGR of 4.50% in the next 5 years, which will be mainly driven by increased penetration of organized Pharma retail chains like Apollo Pharmacy, MedPlus etc.

The report also has detailed company profiles including their position in pharmaceuticals industry value chain, financial performance analysis, product and service wise business strategy, SWOT analysis and key customer details for sixteen key players in Indian market namely Abbott India, Biocon Limited, CIPLA Limited, Dr. Reddy’s Laboratories, Sun Pharmaceuticals Limited, Lupin Limited, Aurobindo Pharma Limited, Torrent Pharmaceuticals Limited, Divis Laboratories Limited, IPCA Laboratories Limited, Beacton Dickinson & Company Limited, Poly Medicure Limited, Novartis India Limited, Apollo Pharmacy, MedPlus Health Services Pvt. Ltd. and National Institute of Pharmaceutical Education and Research (NIPER).

 

Scope of Pharmaceuticals Industry in India 2015 - 2020 report:

• This report provides a detailed view of Indian pharmaceuticals market with current available capacity and options.
• This report identifies the need for focusing on pharmaceuticals sector in India.
• This report provides detailed information on growth forecasts for overall pharmaceuticals industry in India up to 2020.
• This report provides detailed information on growth forecasts for pharmaceuticals manufacturing industry in India up to 2020.
• This report provides detailed information on growth forecasts for pharma services industry in India up to 2020.
• This report provides detailed information on growth forecasts for pharmaceuticals packaging industry in India up to 2020.
• This report provides detailed information on growth forecasts for pharmaceuticals retail industry in India up to 2020.
• The report identifies the growth drivers and inhibitors for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
• This study also identifies policies related to pharmaceuticals market in India for various sectors.
• The report identifies various credit, policy and technical risks associated with pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging, pharmaceuticals retail, and pharmaceuticals R&D industry in India.
• The report identifies EXIM scenario for pharmaceuticals products and medical devices market in India.
• The report identifies top countries exporting pharmaceuticals products and medical devices to India.
• The report identifies top countries importing pharmaceuticals products and medical devices from India.
• This report has detailed profiles 16 key players in Indian pharmaceuticals market covering their value chain analysis, business strategy, financial performance, future forecasts and SWOT analysis.
• This report covers in details the competitive landscape in Indian pharmaceuticals market.
• This report identifies key industry bodies and associations and their role in Indian pharmaceuticals market.
• This report identifies key government bodies and their role in Indian pharmaceuticals market.
• This report provides PESTLE (political, economic, social, technological, legal and environmental) analysis for Indian pharmaceuticals market.
• This report provides Porter's Five Forces analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
• This report provides SWOT (strengths, weakness, opportunities and threats) analysis for pharmaceuticals manufacturing, medical devices manufacturing, pharmaceuticals services, pharmaceuticals packaging and pharmaceuticals retail and pharmaceuticals R&D industry in India.
• This report provides future trends and opportunities for pharmaceuticals market in India.
• This report also provides strategic recommendations for policy makers, pharmaceuticals manufacturers and end users.

For more information and purchase this report please visit: http://www.marketresearchreports.com/novonous/pharmaceuticals-industry-india-2015-2020

To browse more market research reports by NOVONOUS visit:

http://www.marketresearchreports.com/publisher/novonous

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions